PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33535045-5	2021	Myofibroblast MyD88-deficient mice are resistant to azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced tumorigenesis, as evidenced by the decrease in the number and sizes of tumors.	Azoxymethane	52-64	myeloid differentiation primary response gene 88	Mus musculus	14-19	
33535045-5	2021	Myofibroblast MyD88-deficient mice are resistant to azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced tumorigenesis, as evidenced by the decrease in the number and sizes of tumors.	Azoxymethane	66-69	myeloid differentiation primary response gene 88	Mus musculus	14-19	
20624890-2	2010	In contrast, MyD88 signaling has a protective role in the development of azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC).	Azoxymethane	73-85	myeloid differentiation primary response gene 88	Mus musculus	13-18	
20624890-2	2010	In contrast, MyD88 signaling has a protective role in the development of azoxymethane (AOM)/dextran sodium sulfate (DSS) colitis-associated cancer (CAC).	Azoxymethane	87-90	myeloid differentiation primary response gene 88	Mus musculus	13-18